Yuki Kageyama to Retrospective Studies
This is a "connection" page, showing publications Yuki Kageyama has written about Retrospective Studies.
Connection Strength
0.370
-
STAT3 Contributes a Favorable Response to Pembrolizumab Through IFN-?-induced Apoptosis in Urothelial Cancer. Anticancer Res. 2024 May; 44(5):1925-1930.
Score: 0.065
-
Clinical outcomes of nivolumab plus ipilimumab in patients with metastatic non-clear cell renal cell carcinoma: Real-world data from a Japanese multicenter retrospective study. Int J Urol. 2023 09; 30(9):714-721.
Score: 0.059
-
Platelet-to-Lymphocyte Ratio Predicts the Efficacy of Pembrolizumab in Patients With Urothelial Carcinoma. Anticancer Res. 2022 Feb; 42(2):1131-1136.
Score: 0.056
-
The processus vaginalis transection method is superior to the simple prophylactic procedure for prevention of inguinal hernia after radical prostatectomy. Int J Clin Oncol. 2016 Apr; 21(2):384-388.
Score: 0.036
-
Severely affected ALS patients have broad and high expectations for brain-machine interfaces. Amyotroph Lateral Scler Frontotemporal Degener. 2014 Dec; 15(7-8):513-9.
Score: 0.033
-
Peritoneal closure and the processus vaginalis transection method to prevent inguinal hernia after robot-assisted radical prostatectomy. Int J Urol. 2023 06; 30(6):532-538.
Score: 0.015
-
Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab. J Immunother Cancer. 2021 02; 9(2).
Score: 0.013
-
Impact of radiotherapy to the primary tumor on the efficacy of pembrolizumab for patients with advanced urothelial cancer: A preliminary study. Cancer Med. 2020 11; 9(22):8355-8363.
Score: 0.013
-
Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature Review. Clin Genitourin Cancer. 2021 06; 19(3):208-216.e1.
Score: 0.013
-
Contact with renal sinus is associated with poor prognosis in surgically treated pT1 clear cell renal cell carcinoma. Int J Urol. 2020 Aug; 27(8):657-662.
Score: 0.012
-
[Relationship between pretreatment serum levels of prostate specific antigen and bone metastasis in prostate cancer]. Hinyokika Kiyo. 1996 Mar; 42(3):197-9.
Score: 0.009
-
Young age as favorable prognostic factor for cancer-specific survival in localized renal cell carcinoma. Urology. 2011 Apr; 77(4):842-7.
Score: 0.006
-
[Result of treatment for advanced germ cell tumor in the last decade]. Nihon Hinyokika Gakkai Zasshi. 2010 Mar; 101(3):539-46.
Score: 0.006
-
Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low-dose chemo-radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single-institutional retrospective comparative study. BJU Int. 2009 Jul; 104(2):189-94.
Score: 0.006
-
Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases. J Urol. 2008 Aug; 180(2):618-21; discussion 621.
Score: 0.005
-
C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy. BJU Int. 2008 Apr; 101(8):978-81.
Score: 0.005
-
The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically. BJU Int. 2007 Aug; 100(2):269-73.
Score: 0.005
-
HSP60 may predict good pathological response to neoadjuvant chemoradiotherapy in bladder cancer. Jpn J Clin Oncol. 2007 Jan; 37(1):56-61.
Score: 0.005
-
Stronger suppression of serum testosterone and FSH levels by a synthetic estrogen than by castration or an LH-RH agonist. Endocr J. 1997 Aug; 44(4):527-32.
Score: 0.003
-
Treatment of hypertensive cerebellar hemorrhage--surgical or conservative management? Neurosurgery. 1994 Feb; 34(2):246-50; discussion 250-1.
Score: 0.002
-
[Amyloidosis associated with rheumatoid arthritis after total joint replacement]. Ryumachi. 1992 Oct; 32(5):432-6.
Score: 0.002